Search Results 91-100 of 81942 for Melanoma
— People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. While ...
A Mayo Clinic study finds that people with a condition called monoclonal B-cell lymphocytosis (MBL) have a heightened melanoma risk.
About this study. A Postmarketing Prospective Cohort Study of Melanoma Patients Treated With IMLYGIC® (Talimogene Laherparepvec) in Clinical Practice to ...
"Based on this data, we are suggesting that physicians appropriately counsel IBD patients about the risk of melanoma. Sun-protective measures are very effective ...
Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
Backed by robust resources, the Melanoma and Skin Cancer Research Program at Mayo Clinic mentors, educates and prepares professionals for careers in ...
Giving imiquimod and pembrolizumab may work better at treating melanoma. Participation eligibility. Participant eligibility includes age, gender, type and stage ...
... Melanoma or Melanoma that has spread. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
This cancer comes in two main types: melanoma, which is less common but more deadly, and nonmelanoma skin cancers, which include basal cell carcinoma and ...
Melanoma affects sun-exposed skin, but also can occur on skin that hasn't been exposed to the sun. Skyrocketing rates. Skin cancer is the by far the most common ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!